Simtuzumab (Anti-LOXL2)

Simtuzumab (Anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2) with potential antineoplastic activity. MW: 145.5 kD.
Supplier Selleck Chemicals
Product # A2408
Sku # A2408-1mg*5
Pricing 1mg*5, $790.00
Feedback